Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study | BLOOD |